Ultrasound Diagnosis of Non-melanoma Skin Cancer and Malignant Melanoma

2019 ◽  
pp. 43-55
Author(s):  
Robert L. Bard ◽  
Ximena Wortsman
Keyword(s):  
Skin Cancer ◽  
Malignant Melanoma ◽  
Ultrasound Diagnosis ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Oxidative stress in malignant melanoma and non-melanoma skin cancer

2003 ◽  
Vol 148 (5) ◽  
pp. 913-922 ◽  
Author(s):  
C.S. Sander ◽  
F. Hamm ◽  
P. Elsner ◽  
J.J. Thiele
Keyword(s):  
Oxidative Stress ◽  
Skin Cancer ◽  
Malignant Melanoma ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Skin cancer

2007 ◽  
pp. 465-468
Keyword(s):  
Skin Cancer ◽  
Malignant Melanoma ◽  
Uv Radiation ◽  
Basal Layer ◽  
The Body ◽  
Malignant Melanomas ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Malignant melanoma 466 Non-melanoma skin cancer 468 • Malignant melanomas arise from melanocytes, mainly found in the basal layer of skin. These cells produce melanin and are responsible for the tanning response after exposure to ultraviolet (UV) radiation. • A few melanocytes exist elsewhere in the body—this explains the rare melanomas that can occur elsewhere, e.g. intracocular, oesophageal....

scholarly journals Obesity and Risks for Malignant Melanoma and Non-Melanoma Skin Cancer: Results from a Large Danish Prospective Cohort Study

2015 ◽  
Vol 135 (3) ◽  
pp. 901-904 ◽  
Author(s):  
Camilla Præstegaard ◽  
Susanne K. Kjær ◽  
Jane Christensen ◽  
Anne Tjønneland ◽  
Jytte Halkjær ◽  
...  
Keyword(s):  
Cohort Study ◽  
Skin Cancer ◽  
Malignant Melanoma ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin

Skin cancer

2019 ◽  
pp. 445-452
Author(s):  
Heidi Allen
Keyword(s):  
Risk Factors ◽  
Drug Therapy ◽  
Skin Cancer ◽  
Malignant Melanoma ◽  
Early Stage ◽  
Non Melanoma Skin Cancer ◽  
Recent Developments ◽  
Adjuvant Drug Therapy ◽  
Melanoma Skin

This chapter focuses on the management of skin cancer, exploring both malignant melanoma and non-melanoma skin cancer. The epidemiology of melanoma is covered, and risk factors are described. Management looks at both early-stage and widespread disease, including surgery, adjuvant drug therapy, and radiotherapy. There is further emphasis on recent developments in biological and immunotherapy treatments such as ipilimumab and nivolumab. Non-melanoma skin cancer is discussed, covering risk factors and presentation of these diseases and a summary of their management.

Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer

2016 ◽  
Vol 17 (3) ◽  
pp. 389-403 ◽  
Author(s):  
K. Karimi ◽  
T. H. Lindgren ◽  
C. A. Koch ◽  
Robert T. Brodell
Keyword(s):  
Risk Factor ◽  
Skin Cancer ◽  
Malignant Melanoma ◽  
Non Melanoma Skin Cancer ◽  
Melanoma Skin
Sign in / Sign up

Export Citation Format

Share Document